- Filings
-
Holdings
- Share Price
-
Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
- Financials
CSLM Acquisition (FUSE) Financial statements
Company Profile
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Total Revenue | |||||
| Cost of Revenue | |||||
| Gross Profit | |||||
| Gross Profit Margin (%) | |||||
| R&D Expense | |||||
| SG&A Expense | |||||
| Total Operating Expenses | |||||
| Operating Income or Loss | |||||
| Operating Margin (%) | |||||
| Interest Expense | |||||
| Total Other Income/Expenses | |||||
| Income Before Tax | |||||
| Income Tax Expense | |||||
| Income from Continuing Ops. | |||||
| Net Income | |||||
| Net Profit Margin (%) | |||||
| Net Income Available to Common Shareholders | |||||
| Basic EPS | |||||
| Diluted EPS | |||||
| Basic Average Shares | |||||
| Diluted Average Shares |
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ||||||||||||||||
| Cost of Revenue | ||||||||||||||||
| Gross Profit | ||||||||||||||||
| Gross Profit Margin (%) | ||||||||||||||||
| R&D Expense | ||||||||||||||||
| SG&A Expense | ||||||||||||||||
| Total Operating Expenses | ||||||||||||||||
| Operating Income or Loss | ||||||||||||||||
| Operating Margin (%) | ||||||||||||||||
| Interest Expense | ||||||||||||||||
| Total Other Income/Expenses | ||||||||||||||||
| Income Before Tax | ||||||||||||||||
| Income Tax Expense | ||||||||||||||||
| Income from Continuing Ops. | ||||||||||||||||
| Net Income | ||||||||||||||||
| Net Profit Margin (%) | ||||||||||||||||
| Net Income Available to Common Shareholders | ||||||||||||||||
| Basic EPS | ||||||||||||||||
| Diluted EPS | ||||||||||||||||
| Basic Average Shares | ||||||||||||||||
| Diluted Average Shares |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash & Cash Equivalents | |||||
| Marketable Securities | |||||
| Receivables | |||||
| Inventories | |||||
| Other Current Assets | |||||
| Total Current Assets | |||||
| Non-Current Assets | |||||
| Marketable Securities | |||||
| PPE Net | |||||
| Intangibles inc. Goodwill | |||||
| Other Non-Current Assets | |||||
| Total Non-Current Assets | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accounts Payable | |||||
| Deferred Revenues | |||||
| Debt, Current | |||||
| Accrued Liabilities | |||||
| Other Current Liabilities | |||||
| Total Current Liabilities | |||||
| Non-Current Liabilities | |||||
| Deferred Revenues | |||||
| Debt, Non-Current | |||||
| Other Non-Current Liabilities | |||||
| Total Non-Current Liabilities | |||||
| Total Liabilities | |||||
| Shareholders' Equity | |||||
| Common Stock | |||||
| Additional Paid-In Capital | |||||
| Retained Earnings | |||||
| Other Shareholders' Equity | |||||
| Total Shareholders' Equity | |||||
| Total Liabilities & Shareholders' Equity |
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||
| Cash & Cash Equivalents | ||||||||||||||||
| Marketable Securities | ||||||||||||||||
| Receivables | ||||||||||||||||
| Inventories | ||||||||||||||||
| Other Current Assets | ||||||||||||||||
| Total Current Assets | ||||||||||||||||
| Non-Current Assets | ||||||||||||||||
| Marketable Securities | ||||||||||||||||
| PPE Net | ||||||||||||||||
| Intangibles inc. Goodwill | ||||||||||||||||
| Other Non-Current Assets | ||||||||||||||||
| Total Non-Current Assets | ||||||||||||||||
| Total Assets | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payable | ||||||||||||||||
| Deferred Revenues | ||||||||||||||||
| Debt, Current | ||||||||||||||||
| Accrued Liabilities | ||||||||||||||||
| Other Current Liabilities | ||||||||||||||||
| Total Current Liabilities | ||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||
| Deferred Revenues | ||||||||||||||||
| Debt, Non-Current | ||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||
| Total Non-Current Liabilities | ||||||||||||||||
| Total Liabilities | ||||||||||||||||
| Shareholders' Equity | ||||||||||||||||
| Common Stock | ||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||
| Retained Earnings | ||||||||||||||||
| Other Shareholders' Equity | ||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||
| Total Liabilities & Shareholders' Equity |
| Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | ||
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net Income | |||||
| Depreciation & Amortization | |||||
| Deferred Income Taxes | |||||
| Stock Based Compensation | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Accounts Payable | |||||
| Deferred Revenue | |||||
| Other Non-Cash | |||||
| Operating Cash Flow | |||||
| Cash Flows from Investing Activities | |||||
| PPE Investments | |||||
| Net Acquisitions | |||||
| Purchase of Investments | |||||
| Sale of Investments | |||||
| Other Investing Activity | |||||
| Investing Cash Flow | |||||
| Cash Flows from Financing Activities | |||||
| Debt Issued | |||||
| Proceeds from Debt Repayment | |||||
| Debt Repayment | |||||
| Proceeds from Sale of Equity | |||||
| Equity Repurchased | |||||
| Dividend Paid | |||||
| Other Financing Activity | |||||
| Financing Cash Flow | |||||
| Cash Position | |||||
| Beginning Cash Position | |||||
| End Cash Position | |||||
| Change in Cash | |||||
| Free Cash Flow | |||||
| Operating Cash Flow | |||||
| Capital Expenditure | |||||
| Free Cash Flow |
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | ||||||||||||||||
| Net Income | ||||||||||||||||
| Depreciation & Amortization | ||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||
| Stock Based Compensation | ||||||||||||||||
| Accounts Receivable | ||||||||||||||||
| Inventory | ||||||||||||||||
| Accounts Payable | ||||||||||||||||
| Deferred Revenue | ||||||||||||||||
| Other Non-Cash | ||||||||||||||||
| Operating Cash Flow | ||||||||||||||||
| Cash Flows from Investing Activities | ||||||||||||||||
| PPE Investments | ||||||||||||||||
| Net Acquisitions | ||||||||||||||||
| Purchase of Investments | ||||||||||||||||
| Sale of Investments | ||||||||||||||||
| Other Investing Activity | ||||||||||||||||
| Investing Cash Flow | ||||||||||||||||
| Cash Flows from Financing Activities | ||||||||||||||||
| Debt Issued | ||||||||||||||||
| Proceeds from Debt Repayment | ||||||||||||||||
| Debt Repayment | ||||||||||||||||
| Proceeds from Sale of Equity | ||||||||||||||||
| Equity Repurchased | ||||||||||||||||
| Dividend Paid | ||||||||||||||||
| Other Financing Activity | ||||||||||||||||
| Financing Cash Flow | ||||||||||||||||
| Cash Position | ||||||||||||||||
| Beginning Cash Position | ||||||||||||||||
| End Cash Position | ||||||||||||||||
| Change in Cash | ||||||||||||||||
| Free Cash Flow | ||||||||||||||||
| Operating Cash Flow | ||||||||||||||||
| Capital Expenditure | ||||||||||||||||
| Free Cash Flow |